Bio-Rad Laboratories BIO
NYSE BIO
$376.41 +12.15 (+3.34%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026)

Bio-Rad Laboratories (BIO) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 12.44%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 6.92%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 8.48%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 19.21%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 6.67%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 8.23%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 6.21%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -1.40%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 5.69%
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn -5.78%

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.78%
Mar 31, 2026 -0.19%
Dec 31, 2025 2.23%
Sep 30, 2025 -0.94%
Jun 30, 2025 2.99%
Mar 31, 2025 1.17%
Dec 31, 2024 -0.17%
Sep 30, 2024 6.63%
Jun 30, 2024 3.84%
Mar 31, 2024 3.14%
Dec 31, 2023 6.09%
Sep 30, 2023 10.90%
Jun 30, 2023 9.06%
Mar 31, 2023 4.26%
Dec 31, 2022 -2.55%
Sep 30, 2022 -3.26%
Jun 30, 2022 -2.22%
Mar 31, 2022 0.63%
Dec 31, 2021 4.12%
Sep 30, 2021 -0.89%